Sera Prognostics, Inc. SEC filings SERA
Sera Prognostics, Inc. has 660 filings in SEC EDGAR's recent list, going back to Nov 21, 2011. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 19, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 30, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| DEFA14A | Additional proxy material | Jun 1, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jun 1, 2026 | May 26, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Apr 23, 2026 |
| 424B5 | Prospectus supplement | Mar 18, 2026 | — |
| S-8 | Employee stock plan registration | Mar 18, 2026 | — |
| 10-K | Annual report | Mar 18, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 24, 2025 | Nov 24, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2025 | Sep 5, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Jun 5, 2025 |
| S-8 | Employee stock plan registration | Mar 19, 2025 | — |
| 10-K | Annual report | Mar 19, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Feb 12, 2025 | Feb 10, 2025 |
| 424B5 | Prospectus supplement | Feb 11, 2025 | — |
| 424B5 | Prospectus supplement | Feb 10, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 10, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 31, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2025 | Jan 6, 2025 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| EFFECT | Filing | Aug 13, 2024 | — |
| 424B5 | Prospectus supplement | Aug 13, 2024 | — |
| CORRESP | Letter to the SEC | Aug 9, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2024 | — |
| S-3 | Shelf registration | Aug 7, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 6, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| ARS | Annual report to shareholders | Apr 23, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Jun 6, 2024 |
| S-8 | Employee stock plan registration | Mar 20, 2024 | — |
| 10-K | Annual report | Mar 20, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 20, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 12, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2023 | Dec 6, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 25, 2023 | Sep 25, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 31, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 14, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 25, 2023 | May 22, 2023 |
| 8-K |
Current report
Officer or director change
|
May 19, 2023 | May 15, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 16, 2023 | May 14, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| ARS | Annual report to shareholders | Apr 25, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 25, 2023 | — |
| DEF 14A | Proxy statement | Apr 25, 2023 | Jun 8, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2023 | Jun 8, 2023 |
| S-8 | Employee stock plan registration | Mar 22, 2023 | — |
| 10-K | Annual report | Mar 22, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Material agreement
|
Feb 22, 2023 | Feb 16, 2023 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 29, 2022 | Apr 11, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 29, 2022 | Nov 29, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 29, 2022 | Nov 8, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2022 | Jun 3, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 22, 2022 | Jun 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2022 | Apr 11, 2022 |
| S-8 | Employee stock plan registration | Mar 29, 2022 | — |
| 10-K | Annual report | Mar 29, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2022 | Mar 29, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 30, 2021 | Nov 29, 2021 |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Officer or director change
|
Nov 8, 2021 | Nov 8, 2021 |
| 10-Q | Quarterly report | Aug 30, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 30, 2021 | Aug 30, 2021 |
| S-8 | Employee stock plan registration | Aug 11, 2021 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 20, 2021 | Jul 19, 2021 |
| 424B4 | Prospectus | Jul 16, 2021 | — |
| SEC STAFF LETTER | Filing | Jul 14, 2021 | — |
| EFFECT | Filing | Jul 14, 2021 | — |
| CERT | Filing | Jul 14, 2021 | — |
| 8-A12B | Filing | Jul 14, 2021 | — |
| CORRESP | Letter to the SEC | Jul 12, 2021 | — |
| CORRESP | Letter to the SEC | Jul 12, 2021 | — |
| S-1/A | Amended registration statement | Jul 8, 2021 | — |
| CORRESP | Letter to the SEC | Jun 21, 2021 | — |
| CORRESP | Letter to the SEC | Jun 11, 2021 | — |
| S-1 | Registration statement | Jun 11, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 3, 2021 | — |
| DRSLTR | Filing | May 27, 2021 | — |
| DRS/A | Filing | May 27, 2021 | — |
| SEC STAFF LETTER | Filing | May 14, 2021 | — |
| UPLOAD | Letter from the SEC | May 14, 2021 | — |
| D/A | Filing | May 11, 2021 | — |
| DRSLTR | Filing | May 5, 2021 | — |
| DRS/A | Filing | May 5, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 26, 2021 | — |
| D | Filing | Apr 5, 2021 | — |
| DRS | Filing | Mar 29, 2021 | — |
| D/A | Filing | Feb 27, 2020 | — |
| D | Filing | Aug 7, 2019 | — |
| D | Filing | Mar 8, 2019 | — |
| D | Filing | Dec 6, 2018 | — |
| D | Filing | Jan 23, 2017 | — |
| D | Filing | Nov 18, 2014 | — |
| D | Filing | Jun 10, 2014 | — |
| D/A | Filing | Mar 13, 2014 | — |
| D | Filing | Oct 2, 2013 | — |
| D/A | Filing | Nov 20, 2012 | — |
| D | Filing | Nov 21, 2011 | — |
Showing 143 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- SERA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Salt Lake City, UT
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1534969
- Former names
- SERA PROGNOSTICS, INC. (until Nov 4, 2026)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.